News: Research

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as similar coronaviruses.

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.

An innovative approach uses artificial intelligence and biosensors to pave the way for faster drug development.

Yi Lu and Lauren Ehrlich of the College of Natural Sciences are among the cancer researchers with exciting projects on the horizon.

Epidemiologists found that treating even 20% of symptomatic cases would save lives and improve public health.

Bacteria use iron levels to store memories and pass them on to later generations, scientists have found.

A team of researchers at The University of Texas at Austin and other institutions have unlocked a clue about how bacteria form biofilms.

A team led by Lauren Ehrlich found a link between myeloid cells and the cancer that often strikes children.

Drug candidate developed by Everett Stone and his team is effective in mice with cancers of skin, bladder, blood and colon.

A study in PLOS Computational Biology from University of Texas at Austin epidemiologists examined COVID infection and hospitalization rates by zip code.